Akoya Biosciences Inc (AKYA)
3.238
0.00 (0.00%)
USD |
NASDAQ |
Nov 07, 16:00
3.23
-0.01
(-0.25%)
After-Hours: 20:00
Akoya Biosciences Revenue (TTM): 93.22M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 93.22M |
| March 31, 2024 | 93.57M |
| December 31, 2023 | 96.63M |
| September 30, 2023 | 91.36M |
| June 30, 2023 | 85.00M |
| March 31, 2023 | 79.38M |
| December 31, 2022 | 74.86M |
| September 30, 2022 | 69.80M |
| Date | Value |
|---|---|
| June 30, 2022 | 64.42M |
| March 31, 2022 | 59.60M |
| December 31, 2021 | 54.92M |
| September 30, 2021 | 51.67M |
| June 30, 2021 | 48.14M |
| March 31, 2021 | 43.63M |
| December 31, 2020 | 42.44M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
42.44M
Minimum
Dec 2020
96.63M
Maximum
Dec 2023
69.91M
Average
69.80M
Median
Sep 2022
Revenue (TTM) Benchmarks
| Bruker Corp | 3.241B |
| Azenta Inc | 658.62M |
| Harvard Bioscience Inc | 101.12M |
| Bionano Genomics Inc | 36.58M |
| Singular Genomics Systems Inc | 2.722M |